Gynecologic Cancer
From the Journals
Cancer mortality continues to drop in females as breast cancer reversal looms
Gains were strongest for melanoma and lung cancer, while ground was lost to uterine cancer.
News
CDC notes sharp declines in breast and cervical cancer screening
The new data come from the National Breast and Cervical Cancer Early Detection Program, which provides cancer screening services to women with low...
From the Journals
Racial and economic disparities persist in endometrial cancer care
Fewer Black, Latina, Alaska Native, and American Indian women receive guidelines-based treatment.
Opinion
Decision making regarding LEEP versus cone biopsy for excision of cervical dysplasia
While both techniques are associated with equivalent efficacy in disease control, each has its virtues and advantages, and clinical judgment is...
Conference Coverage
Cervical cancer rates fall, but other HPV cancers increase
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Conference Coverage
For cervical cancer screening, any strategy is acceptable
Plus, an expert explains why increased rates of HPV vaccination may affect future screening guidelines.
Conference Coverage
Success in LGBTQ+ medicine requires awareness of risk
Cross-sex hormone therapy is a life-sustaining treatment that should be viewed analogously with any other long-term management strategy, such as...
From the Journals
Hyperprogression on immunotherapy: When outcomes are much worse
Opinion
Surgery for early-stage cervical cancer: Are we still too radical?
Radical vaginal or abdominal trachelectomy is associated with cancer recurrence rates of less than 5% and successful pregnancy in approximately...
News from the FDA/CDC
FDA approves new immunotherapy for endometrial cancer
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair.